Individualized Analgesia for Pediatric Adenotonsillectomy
Primary Purpose
Adenotonsillectomy, Analgesia
Status
Recruiting
Phase
Phase 4
Locations
China
Study Type
Interventional
Intervention
Individualized oral morphine
Conventional oral morphine
Sponsored by
About this trial
This is an interventional treatment trial for Adenotonsillectomy focused on measuring adenotonsillectomy, individualized opioid analgesia, respiratory parameters, children
Eligibility Criteria
Inclusion Criteria:
- Children, ASA physical status I or II, who is scheduled to undergo adenotonsillectomy will be recruited.
Exclusion Criteria:
- Children with craniofacial deformities, neuromuscular diseases, mental retardation, body mass index > 30kg/m2 , or a recent history of opioid use are excluded.
Sites / Locations
- Children's hospital of Fudan universityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
individualized opioid analgesia regimen group
conventional opioid analgesia regimen group
Arm Description
The dose of oral morphine for patients in the individualized group is determined according to the results of fentanyl test.
Patients in the conventional group are given routine dose of oral morphine.
Outcomes
Primary Outcome Measures
Desaturation events
The oxygen saturation per night during sleep will be monitored using a pulse oximeter by the parents from postoperative Day 1 to Day 10. The research team will instruct parents on how to properly apply the oximeter to the child and repeat these measurements. The primary outcome measure is desaturation events during sleep per night.
Secondary Outcome Measures
Scores of Pain Scale (the Faces Scale)
Analgesic effectiveness was assessed using the Faces Scale by the parents every four hours from postoperative Day 1 to Day 10. Parents are trained by the research staff on how to complete pain scale.
Scores of Pain Scale (the Objective Pain Scale)
Analgesic effectiveness was assessed using the Objective Pain Scale by the parents every four hours from postoperative Day 1 to Day 10. Parents are trained by the research staff on how to complete pain scale.
Tonsillar bleeding events
This include any signs of significant oral or nasal bleeding. It is recorded by the parents as occurring or not; if so, the number of occurrences and the time of each occurrence should be recorded.
Adverse drug reactions
It is recorded by the parents as occurring or not; if so, the time of occurrence and the type of adverse reaction need to be recorded.
Full Information
NCT ID
NCT04527393
First Posted
August 24, 2020
Last Updated
September 24, 2023
Sponsor
Children's Hospital of Fudan University
1. Study Identification
Unique Protocol Identification Number
NCT04527393
Brief Title
Individualized Analgesia for Pediatric Adenotonsillectomy
Official Title
Effects of Individualized Opioid Analgesia Versus Conventional Opioid Analgesia After Adenotonsillectomy in Children
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 1, 2022 (Actual)
Primary Completion Date
December 20, 2023 (Anticipated)
Study Completion Date
March 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital of Fudan University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The objective of this randomized clinical trial is to assess the safety and effectiveness of post-adenotonsillectomy analgesia with individualized opioid analgesia regime in children.
Detailed Description
Patients will be randomly assigned to individualized opioid analgesia regimen group or conventional opioid analgesia regimen group.
Intravenous 1μg/kg fentanyl is administered as a test in patients with spontaneous breath after sevoflurane induction. A positive result is defined as a decrease of more than 50% in spontaneous respiratory rate (rate after fentanyl test versus rate before fentanyl test). Otherwise it is defined as a negative result.
All the patients are given regular paracetamol and ibuprofen after surgery. The addition of rescue oral morphine is given as needed. The dose of oral morphine is determined according to the results of fentanyl test in the individualized group, while the patients in the conventional group are given the routine dose. The Faces Scale is used to assess analgesic effectiveness by parents from postoperative day 1 to day 10. If the Faces Scale score > 6, the child receive rescue oral morphine analgesia.
At the preoperative appointment, parents are provided with a pulse oximeter including oxygen saturation sensors to take home. The oxygen saturation per night during sleep will be monitored using the pulse oximeter by parents from postoperative Day 1 to Day 10. The research team will instruct parents on how to properly apply the oximeter to the child and repeat these measurements. The primary outcome measure is desaturation events during sleep per night.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adenotonsillectomy, Analgesia
Keywords
adenotonsillectomy, individualized opioid analgesia, respiratory parameters, children
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
128 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
individualized opioid analgesia regimen group
Arm Type
Experimental
Arm Description
The dose of oral morphine for patients in the individualized group is determined according to the results of fentanyl test.
Arm Title
conventional opioid analgesia regimen group
Arm Type
Active Comparator
Arm Description
Patients in the conventional group are given routine dose of oral morphine.
Intervention Type
Drug
Intervention Name(s)
Individualized oral morphine
Intervention Description
Analgesic effectiveness is assessed using the Faces Scale by the parents every four hours from postoperative Day 1 to Day 10 (eg: 8:00, 12:00, 16:00, and 20:00, each day).
If the Faces Scale score > 6, the child receive rescue oral morphine analgesia. Patients with positive results of fentanyl test receive oral morphine 100μg/kg per dose, while patients with negative results receive oral morphine 500μg/kg per dose.
Intervention Type
Drug
Intervention Name(s)
Conventional oral morphine
Intervention Description
Analgesic effectiveness is assessed using the Faces Scale by the parents every four hours from postoperative Day 1 to Day 10 (eg: 8:00, 12:00, 16:00, and 20:00, each day).
If the Faces Scale score > 6, the child receive rescue oral morphine analgesia. Patients receive oral morphine 200μg/kg per dose.
Primary Outcome Measure Information:
Title
Desaturation events
Description
The oxygen saturation per night during sleep will be monitored using a pulse oximeter by the parents from postoperative Day 1 to Day 10. The research team will instruct parents on how to properly apply the oximeter to the child and repeat these measurements. The primary outcome measure is desaturation events during sleep per night.
Time Frame
from postoperative day 1 to day 10, each night
Secondary Outcome Measure Information:
Title
Scores of Pain Scale (the Faces Scale)
Description
Analgesic effectiveness was assessed using the Faces Scale by the parents every four hours from postoperative Day 1 to Day 10. Parents are trained by the research staff on how to complete pain scale.
Time Frame
every four hours from postoperative Day 1 to Day 10 (eg: 8:00, 12:00, 16:00, and 20:00, each day)
Title
Scores of Pain Scale (the Objective Pain Scale)
Description
Analgesic effectiveness was assessed using the Objective Pain Scale by the parents every four hours from postoperative Day 1 to Day 10. Parents are trained by the research staff on how to complete pain scale.
Time Frame
every four hours from postoperative Day 1 to Day 10 (eg: 8:00, 12:00, 16:00, and 20:00, each day)
Title
Tonsillar bleeding events
Description
This include any signs of significant oral or nasal bleeding. It is recorded by the parents as occurring or not; if so, the number of occurrences and the time of each occurrence should be recorded.
Time Frame
from postoperative day 1 to day 10
Title
Adverse drug reactions
Description
It is recorded by the parents as occurring or not; if so, the time of occurrence and the type of adverse reaction need to be recorded.
Time Frame
from postoperative day 1 to day 10
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Children, ASA physical status I or II, who is scheduled to undergo adenotonsillectomy will be recruited.
Exclusion Criteria:
Children with craniofacial deformities, neuromuscular diseases, mental retardation, body mass index > 30kg/m2 , or a recent history of opioid use are excluded.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lin He, MD
Phone
(86)13901740886
Email
sarahhelin@163.com
Facility Information:
Facility Name
Children's hospital of Fudan university
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lin He, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Individualized Analgesia for Pediatric Adenotonsillectomy
We'll reach out to this number within 24 hrs